Thus, JTB was found to be upregulated in many tumor tissues, such as primary BC, compared to normal counterparts, ovary, lung, uterus, colon, rectum, thyroid, prostate, stomach, kidney, and small intestine cancer [13], as well as in leukemia [3] and hepatocellular carcinoma (HCC) [14]. Here, JTB is linked to neoplasm.